Practical issues regarding the use of antiretroviral therapy for HIV infection

Western Journal of Medicine

Volumn 168, Issue 2, 1998, Pages 133-139

  Deeks, Steven G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; ANTIRETROVIRUS AGENT; CISAPRIDE; CYTOCHROME P450; DELAVIRDINE; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE DERIVATIVE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; BLOOD TOXICITY; DRUG EFFICACY; DRUG FORMULATION; FATIGUE; GASTROINTESTINAL TOXICITY; GEL; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY COLIC; NEPHROLITHIASIS; PARESTHESIA; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; RASH; REVIEW; TASTE DISORDER; VIRUS RESISTANCE;

ANTI-HIV AGENTS; DRUG INTERACTIONS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; PRACTICE GUIDELINES; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS REPLICATION;

EID: 0031885867     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Sept 28-Oct 1, 1997; Toronto, Canada. Abstract LB-02
2. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. CITY: Department of Health and Human Services, Panel on Clinical Practices for Treatment of HIV Infection; November 5, 1997; Bethesda, MD (See: http://www.hivatis.org)
3. Carpenter CC, Fischl M, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society-USA panel. JAMA 1997; 277:1962-69
4. British HIV Association Guidelines Coordinating Committee. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1997; 349:1086-1092
5. Report on the NIH panel to define principles of therapy of HIV infection (draft document). Washington, DC: National Institutes of Health; June 19, 1996; Bethesda, MD (See: http://www.cdcnac.org)
6. Perelson AS, Neuman AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 1996; 271:1582-1586
7. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995; 267:483-489